Clinical trial
Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation…
NCT00256815 · Clinical Oncology Research Associates, Other · Completed
Key facts
| NCT number | NCT00256815 |
|---|---|
| Title | Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study |
| Lead sponsor | Clinical Oncology Research Associates, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small-Cell Lung |
| Intervention type | Drug, Procedure |
| Interventions | chemotherapy, Radiation |
| Enrollment | 35 |
| Start date | Mar 1, 2003 |
| Completion | Sep 1, 2005 |
| First posted | Nov 22, 2005 |
| Last update posted | Feb 11, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: